Curis Lifesciences Share Price

Curis Lifesciences Limited was originally formed and registered as a Partnership Firm under the Partnership Act, 1932 in the name and style of M/s Loreto Pharmaceutacals, pursuant to a Deed of Partnership dated 2 June, 2010. Thereafter M/s Loreto Pharmaceutacals was converted from Partnership Firm to a Private Limited Company as Curis Lifesciences Private Limited and received a Certificate of Incorporation dated on March 23rd, 2016 issued by Registrar of Companies, Ahmedabad. Subsequently, Company was converted into a Public Limited Company and the name of the Company was changed from Curis Lifesciences Private Limited to Curis Lifesciences Limited vide certified incorporated upon the conversion dated August 9, 2024, issued by the Central Processing Centre, Manesar.Companys business is related to manufacturing of pharmaceutical products for different markets globally as well as domestic. The business is majorly on product to product basis with different marketers. Company has commenced manufacturing facility in year 2017, hence, it has experience of more than 7 years in the current line of business of the Company. The manufacturing facility of the Company is installed with capacity to manufacture 138 Crore tables / year, 15.75 Crore Capsules / year, 1,080 Kilolitre Oral Liquid/ year, 270 Tons external preparation / year and 45 Tons sterile ophthalmic ointment / year. It deal in Pharmaceutical products like Tablets, Capsules, External Preparations, Oral Liquid, Sterile Ophthalmic Ointments etc.The Companys past and present clientele includes renowned pharma marketers and manufactures namely Arova Pharma, Express Pharmaceuticals Private Limited, Angle Biogenics Private Limited, Centurion Healthcare Private Limited, Costcon Healthcare LLP, J.B. Chemical Pharmaceuticals Limited, Venus international, Makers Laboratories Limited and Torikaa Pharmaceuticals Limited etc. pharmaceutical manufacturing facility are situated at Sanand GIDCII in Ahmedabad district of Gujarat, which offers easy and convenient accessibility.Company launched the IPO by raising a fresh issue of Rs 27.52 Crore and issued 21,50,000 equity shares of Rs 10 by way of IPO in Nov25.

As of 21 Jan 2026, Curis Lifesciences share price is ₹118.2. The stock opened at ₹120 and had closed at ₹122.8 the previous day. During today’s trading session, Curis Lifesciences share price moved between ₹118.05 and ₹120.05, with an average price for the day of ₹119.05. Over the last 52 weeks, the stock has recorded a low of ₹107.00 and a high of ₹147.90. In terms of performance, Curis Lifesciences share price has declined by 7.6% over the past six months and has declined by 12.94% over the last year.